Spleen imaging represents a critical component of modern abdominal diagnostics, providing essential insights into the structure, function, and pathology of this often-overlooked lymphatic organ. The spleen, situated in the left upper quadrant beneath the diaphragm, plays a vital role in hematologic regulation, immune surveillance, and blood filtration. Advances in cross-sectional imaging have transformed the detection and characterization of splenic diseases, allowing clinicians to move from vague symptomatology to precise anatomic and functional understanding. This overview details the modalities, indications, and findings central to accurate splenic evaluation.
Modalities and Technical Considerations
The choice of imaging modality for spleen imaging depends on the clinical question, patient factors, and availability. Ultrasound remains the first-line, non-invasive tool due to its wide accessibility, lack of ionizing radiation, and real-time capability. Computed Tomography (CT) offers superior spatial resolution and multiplanar reconstruction, making it the workhorse for trauma and oncologic staging. Magnetic Resonance Imaging (MRI) provides unparalleled soft tissue contrast without radiation, excelling in the characterization of complex lesions and functional assessments. Nuclear medicine techniques, such as Sulfur Colloid scintigraphy, evaluate splenic function and accessory tissue, often in specific hematologic contexts.
Ultrasound and Doppler Applications
Ultrasound evaluates the spleen through a subcostal or left posterior intercostal approach, measuring dimensions and assessing parenchymal echotexture. A normal spleen is homogeneous and slightly hypoechoic relative to the liver, with smooth contours. Doppler imaging is invaluable for assessing vascular patency and flow characteristics, particularly in suspected vascular occlusions or infiltrative diseases. Power Doppler can enhance the visualization of the splenic parenchyma and hilum, aiding in the detection of focal lesions or congestion.
Indications for Clinical Referral
Referral for spleen imaging is prompted by a variety of clinical scenarios. Traumatic injury is a primary indication, ranging from suspected laceration following blunt abdominal trauma to active hemorrhage in polytrauma patients. Oncologic indications include staging hematologic malignancies like lymphoma or leukemia, characterizing splenic masses, and monitoring response to therapy. Non-neoplastic indications encompass evaluating persistent cytopenias, investigating suspected vascular disorders such as portal hypertension, and assessing for congenital anomalies or autoimmune conditions.
Trauma and Acute Abdominal Pain
In trauma, a contrast-enhanced CT scan of the abdomen and pelvis is the standard, utilizing a dedicated spleen protocol with arterial and portal venous phases. The American Association for the Surgery of Trauma (AAST) grading system categorizes injuries from stable subcapsular hematomas (Grade I) to shattered spleens with hilar vascular injury (Grade V). This grading dictates management, from conservative observation to urgent surgical intervention or angioembolization. Accurate imaging prevents unnecessary laparotomy in stable patients.
Pathology and Characterization
Imaging allows for the characterization of a wide spectrum of splenic pathology. Benign lesions include hemangiomas, the most common benign tumor, typically appearing as well-defined, hypovascular masses on CT and demonstrating characteristic bright T2 signal on MRI. Cysts, infarcts, and hematomas are also frequently encountered. Malignant processes range from primary sarcomas and lymphomas to metastatic deposits, often presenting as heterogeneous, enhancing masses with potential areas of necrosis or hemorrhage.
Functional and Molecular Imaging
Beyond anatomy, functional imaging provides crucial information. MRI sequences like T2 mapping and diffusion-weighted imaging (DWI) help differentiate benign from malignant lesions based on tissue cellularity and fluid content. In specific hematologic disorders, radiolabeled tracers in nuclear medicine imaging assess splenic sequestration, as seen in thalassemia or hairy cell leukemia. PET/CT, while not routine, can be valuable for evaluating suspected splenic involvement in systemic lymphomas or infections.
